Thursday, November 20, 2008 - 9:29AM EST

Review Articles

41. Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?

Author
Asirvatham SJ;
Institution
Journal
Circulation. 2007 Nov 27;116(22):2517-9.

42. Atrial fibrillation: insights from clinical trials and novel treatment options.

Author
Blaauw Y; Crijns HJ;
Institution
Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands.
Journal
J Intern Med. 2007 Dec;262(6):593-614.
Abstract URL
Click here to view abstract

43. Atrial fibrillation and the postoperative cardiac surgery patient.

Author
Palazzo MO;
Institution
The Heart Institute, St. Joseph Medical Center, 7601 Osler Drive, Towson, MD 21204, USA. terripalazzo@chi-east.org
Journal
Crit Care Nurs Clin North Am. 2007 Dec;19(4):395-402, vi.
Abstract URL
Click here to view abstract

44. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.

Author
Dale KM; White CM;
Institution
School of Pharmacy, University of Connecticut, Hartford, CT, USA.
Journal
Ann Pharmacother. 2007 Apr;41(4):599-605. Epub 2007 Mar 27.
Abstract URL
Click here to view abstract

45. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis.

Author
Liu T; Li G; Li L; Korantzopoulos P;
Institution
Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
Journal
J Am Coll Cardiol. 2007 Apr 17;49(15):1642-8. Epub 2007 Apr 2.
Abstract URL
Click here to view abstract

46. Is there a link between atrial fibrillation and certain bacterial infections?

Author
Andrew P; Montenero AS;
Institution
aATLAS Medical Research Inc., St Lazare, Quebec, Canada.
Journal
J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):990-6.
Abstract URL
Click here to view abstract

47. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.

Author
Savelieva I; Camm J;
Institution
Division of Cardiac and Vascular Sciences, St George's University of London, London, UK.
Journal
Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):30-41.
Abstract URL
Click here to view abstract

48. Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control.

Author
Sherman DG;
Institution
Division of Neurology/Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. sherman@uthscsa.edu
Journal
Stroke. 2007 Feb;38(2 Suppl):615-7.
Abstract URL
Click here to view abstract

49. Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation.

Author
Bradley DJ; Shen WK;
Institution
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Journal
Clin Pharmacol Ther. 2007 Feb;81(2):284-7.
Abstract URL
Click here to view abstract

50. Current strategies in the surgical treatment of atrial fibrillation: review of the literature and Onze Lieve Vrouw Clinic's strategy.

Author
Bakir I; Casselman FP; Brugada P; Geelen P; Wellens F; Degrieck I; Van Praet F; Vermeulen Y; De Geest R; Vanermen H;
Institution
Cardiovascular and Thoracic Surgery Department, Onze Lieve Vrouw Clinic, Aalst, Belgium.
Journal
Ann Thorac Surg. 2007 Jan;83(1):331-40.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7